3. GOOD HEALTH AND WELL-BEING

Privia Health Group, Inc. (NASDAQ:PRVA) CFO David Mountcastle Sells 1212 Shares – Defense World

Written by Amanda

Privia Health Group, Inc. (NASDAQ:PRVAGet Rating) CFO David Mountcastle sold 1,212 shares of the firm’s stock in a transaction on Thursday, July 7th. The stock was sold at an average price of $32.34, for a total value of $39,196.08. Following the transaction, the chief financial officer now owns 92,651 shares of the company’s stock, valued at $2,996,333.34. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website.

David Mountcastle also recently made the following trade(s):

  • On Tuesday, July 5th, David Mountcastle sold 19,280 shares of Privia Health Group stock. The stock was sold at an average price of $30.73, for a total value of $592,474.40.
  • On Tuesday, June 28th, David Mountcastle sold 32 shares of Privia Health Group stock. The stock was sold at an average price of $30.00, for a total transaction of $960.00.

Shares of PRVA opened at $33.63 on Friday. The stock has a 50 day moving average price of $25.76 and a 200 day moving average price of $24.90. The company has a quick ratio of 2.24, a current ratio of 2.24 and a debt-to-equity ratio of 0.07. The company has a market capitalization of $3.65 billion, a price-to-earnings ratio of -16.49 and a beta of 0.72. Privia Health Group, Inc. has a 52-week low of $17.99 and a 52-week high of $47.77.

Privia Health Group (NASDAQ:PRVAGet Rating) last issued its quarterly earnings data on Thursday, May 12th. The company reported ($0.09) earnings per share for the quarter, topping the consensus estimate of ($0.24) by $0.15. Privia Health Group had a negative net margin of 19.80% and a negative return on equity of 47.87%. The business had revenue of $313.80 million during the quarter, compared to the consensus estimate of $296.36 million. On average, equities analysts anticipate that Privia Health Group, Inc. will post -0.14 EPS for the current fiscal year.

A number of research analysts recently weighed in on PRVA shares. Canaccord Genuity Group dropped their price objective on shares of Privia Health Group from $50.00 to $44.00 and set a “buy” rating for the company in a report on Thursday, March 24th. SVB Leerink upped their price objective on Privia Health Group from $43.00 to $44.00 and gave the stock an “outperform” rating in a research report on Friday, March 25th. Guggenheim started coverage on Privia Health Group in a report on Tuesday, March 29th. They issued a “buy” rating and a $35.00 target price for the company. Canaccord Genuity Group upped their price target on Privia Health Group from $29.00 to $40.00 in a report on Wednesday, June 29th. Finally, BTIG Research started coverage on Privia Health Group in a research note on Thursday, April 28th. They issued a “buy” rating and a $35.00 price objective for the company. Eleven analysts have rated the stock with a buy rating, According to MarketBeat, the company has an average rating of “Buy” and an average target price of $38.45.

Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Rockefeller Capital Management L.P. acquired a new stake in shares of Privia Health Group during the fourth quarter worth about $25,000. First Horizon Advisors Inc. purchased a new position in Privia Health Group during the 4th quarter worth approximately $26,000. FourThought Financial LLC increased its position in Privia Health Group by 77.2% during the first quarter. FourThought Financial LLC now owns 2,417 shares of the company’s stock worth $65,000 after buying an additional 1,053 shares during the period. US Bancorp DE lifted its stake in Privia Health Group by 8.8% in the first quarter. US Bancorp DE now owns 13,923 shares of the company’s stock valued at $372,000 after buying an additional 1,131 shares during the last quarter. Finally, Blair William & Co. IL boosted its holdings in shares of Privia Health Group by 9.2% in the first quarter. Blair William & Co. IL now owns 17,412 shares of the company’s stock valued at $465,000 after acquiring an additional 1,463 shares during the period. Institutional investors own 63.77% of the company’s stock.

About Privia Health Group (Get Rating)

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.

See Also

Receive News & Ratings for Privia Health Group Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Privia Health Group and related companies with MarketBeat.com’s FREE daily email newsletter.

Source: defenseworld.net

About the author

Amanda

Hi there, I am Amanda and I work as an editor at impactinvesting.ai;  if you are interested in my services, please reach me at amanda.impactinvesting.ai